| Trial ID: | L4664 |
| Source ID: | NCT03982238
|
| Associated Drug: |
Insulin
|
| Title: |
Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Insulin|DRUG: Metformin|DRUG: Dapagliflozin
|
| Outcome Measures: |
Primary: total testosterone levels, changes of total testosterone levels, 1 month | Secondary: bioavailable testosterone, changes of bioavailable testosterone, 1 month|free testosterone, changes of free testosterone, 1 month
|
| Sponsor/Collaborators: |
Sponsor: Majianhua
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
74
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2019-06-15
|
| Completion Date: |
2019-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2020-04-03
|
| Locations: |
Nanjing First Hospital, Nanjing, China
|
| URL: |
https://clinicaltrials.gov/show/NCT03982238
|
